In the Kaplan-Meier Plotter database (http://kmplot.com/analysis/), 30 liver cancer patients treated with sorafenib were divided into high expression group and low expression group according to the median expression of FOXQ1, and the prognosis of these 30 patients was analyzed by Kaplan-Meier survival analysis. This evidence concerns the gene FOXQ1 and liver cancer.